{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:32:54Z","timestamp":1791300774620,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7684","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/nature25013","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T10:25:39Z","timestamp":1512555939000},"page":"248-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":168,"title":["Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy"],"prefix":"10.1038","volume":"552","author":[{"given":"Jiong","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dziumbla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia-Iris","family":"Bibli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Zukunft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"de Mos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khader","family":"Awwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Fr\u00f6mel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jungmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavi","family":"Devraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akrit","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Liebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Glaubitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Hammes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Popp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"BFnature25013_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JWY Yau","year":"2012","unstructured":"Yau, J. W. Y. et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35, 556\u2013564 (2012)","journal-title":"Diabetes Care"},{"key":"BFnature25013_CR2","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S2214-109X(13)70113-X","volume":"1","author":"RRA Bourne","year":"2013","unstructured":"Bourne, R. R. A. et al. Causes of vision loss worldwide, 1990\u20132010: a systematic analysis. Lancet Glob. Health 1, e339\u2013e349 (2013)","journal-title":"Lancet Glob. Health"},{"key":"BFnature25013_CR3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti, D. A., Klein, R. & Gardner, T. W. Diabetic retinopathy. N. Engl. J. Med. 366, 1227\u20131239 (2012)","journal-title":"N. Engl. J. Med."},{"key":"BFnature25013_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1242\/dmm.009597","volume":"5","author":"R Robinson","year":"2012","unstructured":"Robinson, R., Barathi, V. A., Chaurasia, S. S., Wong, T. Y. & Kern, T. S. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis. Model. Mech. 5, 444\u2013456 (2012)","journal-title":"Dis. Model. Mech."},{"key":"BFnature25013_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","volume":"34","author":"I Klaassen","year":"2013","unstructured":"Klaassen, I., Van Noorden, C. J. F. & Schlingemann, R. O. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog. Retin. Eye Res. 34, 19\u201348 (2013)","journal-title":"Prog. Retin. Eye Res."},{"key":"BFnature25013_CR6","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1167\/iovs.04-1340","volume":"46","author":"AJ Barber","year":"2005","unstructured":"Barber, A. J. et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest. Ophthalmol. Vis. Sci. 46, 2210\u20132218 (2005)","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnature25013_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1084\/jem.20131494","volume":"211","author":"J Hu","year":"2014","unstructured":"Hu, J. et al. M\u00fcller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid. J. Exp. Med. 211, 281\u2013295 (2014)","journal-title":"J. Exp. Med."},{"key":"BFnature25013_CR8","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1021\/jm070270t","volume":"50","author":"SH Hwang","year":"2007","unstructured":"Hwang, S. H., Tsai, H. J., Liu, J. Y., Morisseau, C. & Hammock, B. D. Orally bioavailable potent soluble epoxide hydrolase inhibitors. J. Med. Chem. 50, 3825\u20133840 (2007)","journal-title":"J. Med. Chem."},{"key":"BFnature25013_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00441-003-0745-x","volume":"314","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt, H. & Betsholtz, C. Endothelial\u2013pericyte interactions in angiogenesis. Cell Tissue Res. 314, 15\u201323 (2003)","journal-title":"Cell Tissue Res."},{"key":"BFnature25013_CR10","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.2337\/diabetes.51.10.3107","volume":"51","author":"HP Hammes","year":"2002","unstructured":"Hammes, H. P. et al. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51, 3107\u20133112 (2002)","journal-title":"Diabetes"},{"key":"BFnature25013_CR11","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1093\/emboj\/cdf418","volume":"21","author":"M Enge","year":"2002","unstructured":"Enge, M. et al. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 21, 4307\u20134316 (2002)","journal-title":"EMBO J."},{"key":"BFnature25013_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#","volume":"218","author":"H Gerhardt","year":"2000","unstructured":"Gerhardt, H., Wolburg, H. & Redies, C. N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken. Dev. Dyn. 218, 472\u2013479 (2000)","journal-title":"Dev. Dyn."},{"key":"BFnature25013_CR13","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.2337\/db06-1694","volume":"56","author":"D Navaratna","year":"2007","unstructured":"Navaratna, D., McGuire, P. G., Menicucci, G. & Das, A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 56, 2380\u20132387 (2007)","journal-title":"Diabetes"},{"key":"BFnature25013_CR14","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/ncb1486","volume":"8","author":"J Gavard","year":"2006","unstructured":"Gavard, J. & Gutkind, J. S. VEGF controls endothelial-cell permeability by promoting the \u03b2-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 8, 1223\u20131234 (2006)","journal-title":"Nat. Cell Biol."},{"key":"BFnature25013_CR15","doi-asserted-by":"publisher","first-page":"17299","DOI":"10.1021\/bi980078g","volume":"37","author":"D Huster","year":"1998","unstructured":"Huster, D., Arnold, K. & Gawrisch, K. Influence of docosahexaenoic acid and cholesterol on lateral lipid organization in phospholipid mixtures. Biochemistry 37, 17299\u201317308 (1998)","journal-title":"Biochemistry"},{"key":"BFnature25013_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbamem.2008.10.011","volume":"1788","author":"SR Wassall","year":"2009","unstructured":"Wassall, S. R. & Stillwell, W. Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes. Biochim. Biophys. Acta 1788, 24\u201332 (2009)","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnature25013_CR17","doi-asserted-by":"publisher","first-page":"e21164","DOI":"10.1371\/journal.pone.0021164","volume":"6","author":"J Cai","year":"2011","unstructured":"Cai, J. et al. PEDF regulates vascular permeability by a \u03b3-secretase-mediated pathway. PLoS One 6, e21164 (2011)","journal-title":"PLoS One"},{"key":"BFnature25013_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S1097-2765(00)80219-1","volume":"4","author":"A Georgakopoulos","year":"1999","unstructured":"Georgakopoulos, A. et al. Presenilin-1 forms complexes with the cadherin\/catenin cell\u2013cell adhesion system and is recruited to intercellular and synaptic contacts. Mol. Cell 4, 893\u2013902 (1999)","journal-title":"Mol. Cell"},{"key":"BFnature25013_CR19","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1073\/pnas.041603398","volume":"98","author":"L Baki","year":"2001","unstructured":"Baki, L. et al. Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin\/p120 association, and regulates stability and function of the cadherin\/catenin adhesion complex. Proc. Natl Acad. Sci. USA 98, 2381\u20132386 (2001)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature25013_CR20","doi-asserted-by":"publisher","first-page":"36007","DOI":"10.1074\/jbc.M507503200","volume":"280","author":"G Serban","year":"2005","unstructured":"Serban, G. et al. Cadherins mediate both the association between PS1 and \u03b2-catenin and the effects of PS1 on \u03b2-catenin stability. J. Biol. Chem. 280, 36007\u201336012 (2005)","journal-title":"J. Biol. Chem."},{"key":"BFnature25013_CR21","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1074\/jbc.M806250200","volume":"284","author":"Z Kouchi","year":"2009","unstructured":"Kouchi, Z . et al. p120 catenin recruits cadherins to \u03b3-secretase and inhibits production of Ab peptide. J. Biol. Chem. 284, 1954\u20131961 (2009)","journal-title":"J. Biol. Chem."},{"key":"BFnature25013_CR22","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1038\/ncomms5509","volume":"5","author":"SK Saka","year":"2014","unstructured":"Saka, S. K. et al. Multi-protein assemblies underlie the mesoscale organization of the plasma membrane. Nat. Commun. 5, 4509 (2014)","journal-title":"Nat. Commun."},{"key":"BFnature25013_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nmeth.2368","volume":"10","author":"JJ Hulce","year":"2013","unstructured":"Hulce, J. J., Cognetta, A. B., Niphakis, M. J., Tully, S. E. & Cravatt, B. F. Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells. Nat. Methods 10, 259\u2013264 (2013)","journal-title":"Nat. Methods"},{"key":"BFnature25013_CR24","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/S0006-2952(02)00952-8","volume":"63","author":"C Morisseau","year":"2002","unstructured":"Morisseau, C. et al. Structural refinement of inhibitors of urea-based soluble epoxide hydrolases. Biochem. Pharmacol. 63, 1599\u20131608 (2002)","journal-title":"Biochem. Pharmacol."},{"key":"BFnature25013_CR25","doi-asserted-by":"publisher","first-page":"14009","DOI":"10.1038\/mtm.2014.9","volume":"1","author":"LP Pellissier","year":"2014","unstructured":"Pellissier, L. P. et al. Specific tools for targeting and expression in M\u00fcller glial cells. Mol. Ther. Methods Clin. Dev. 1, 14009 (2014)","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"BFnature25013_CR26","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1471-4159.2006.03793.x","volume":"97","author":"AR Calabria","year":"2006","unstructured":"Calabria, A. R., Weidenfeller, C., Jones, A. R., de Vries, H. E. & Shusta, E. V. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J. Neurochem. 97, 922\u2013933 (2006)","journal-title":"J. Neurochem."},{"key":"BFnature25013_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/978-1-4939-0320-7_34","volume":"1135","author":"CJ Czupalla","year":"2014","unstructured":"Czupalla, C. J., Liebner, S. & Devraj, K. In vitro models of the blood-brain barrier. Methods Mol. Biol. 1135, 415\u2013437 (2014)","journal-title":"Methods Mol. Biol."},{"key":"BFnature25013_CR28","doi-asserted-by":"publisher","first-page":"e20848","DOI":"10.1371\/journal.pone.0020848","volume":"6","author":"E Bess","year":"2011","unstructured":"Bess, E., Fisslthaler, B., Fr\u00f6mel, T. & Fleming, I. Nitric oxide-induced activation of the AMP-activated protein kinase \u03b12 subunit attenuates I\u03baB kinase activity and inflammatory responses in endothelial cells. PLoS One 6, e20848 (2011)","journal-title":"PLoS One"},{"key":"BFnature25013_CR29","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1038\/emboj.2012.176","volume":"31","author":"I Kovacevic","year":"2012","unstructured":"Kovacevic, I. et al. The F-BAR protein NOSTRIN participates in FGF signal transduction and vascular development. EMBO J. 31, 3309\u20133322 (2012)","journal-title":"EMBO J."},{"key":"BFnature25013_CR30","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1073\/pnas.88.24.11555","volume":"88","author":"HP Hammes","year":"1991","unstructured":"Hammes, H. P., Martin, S., Federlin, K., Geisen, K. & Brownlee, M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl Acad. Sci. USA 88, 11555\u201311558 (1991)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature25013_CR31","doi-asserted-by":"publisher","first-page":"28156","DOI":"10.1074\/jbc.M109.054759","volume":"284","author":"E Barbosa-Sicard","year":"2009","unstructured":"Barbosa-Sicard, E. et al. Inhibition of the soluble epoxide hydrolase by tyrosine nitration. J. Biol. Chem. 284, 28156\u201328163 (2009)","journal-title":"J. Biol. Chem."},{"key":"BFnature25013_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1373\/clinchem.2003.025775","volume":"50","author":"J Rivera","year":"2004","unstructured":"Rivera, J. et al. Measurement of 20-hydroxyeicosatetraenoic acid in human urine by gas chromatography-mass spectrometry. Clin. Chem. 50, 224\u2013226 (2004)","journal-title":"Clin. Chem."},{"key":"BFnature25013_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/BF00167392","volume":"344","author":"R Busse","year":"1991","unstructured":"Busse, R. & Lamontagne, D. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch. Pharmacol. 344, 126\u2013129 (1991)","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"BFnature25013_CR34","doi-asserted-by":"publisher","first-page":"e70233","DOI":"10.1371\/journal.pone.0070233","volume":"8","author":"R Paolinelli","year":"2013","unstructured":"Paolinelli, R. et al. Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro. PLoS One 8, e70233 (2013)","journal-title":"PLoS One"},{"key":"BFnature25013_CR35","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/ncb1752","volume":"10","author":"A Taddei","year":"2008","unstructured":"Taddei, A. et al. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat. Cell Biol. 10, 923\u2013934 (2008)","journal-title":"Nat. Cell Biol."},{"key":"BFnature25013_CR36","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1091\/mbc.e05-05-0440","volume":"16","author":"K Xiao","year":"2005","unstructured":"Xiao, K. et al. p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Mol. Biol. Cell 16, 5141\u20135151 (2005)","journal-title":"Mol. Biol. Cell"},{"key":"BFnature25013_CR37","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1242\/jcs.02541","volume":"118","author":"I Fleming","year":"2005","unstructured":"Fleming, I., Fisslthaler, B., Dixit, M. & Busse, R. Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J. Cell Sci. 118, 4103\u20134111 (2005)","journal-title":"J. Cell Sci."},{"key":"BFnature25013_CR38","doi-asserted-by":"publisher","first-page":"44945","DOI":"10.1074\/jbc.M407986200","volume":"279","author":"KS Vetrivel","year":"2004","unstructured":"Vetrivel, K. S. et al. Association of \u03b3-secretase with lipid rafts in post-Golgi and endosome membranes. J. Biol. Chem. 279, 44945\u201344954 (2004)","journal-title":"J. Biol. Chem."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature25013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature25013","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature25013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature25013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:09:57Z","timestamp":1684433397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature25013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":38,"journal-issue":{"issue":"7684","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFnature25013"],"URL":"https:\/\/doi.org\/10.1038\/nature25013","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"23 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.H., T.F., R.P. and I.F. are authors of patent applications for the use of sEH inhibitors in the treatment of non-proliferative diabetic retinopathy (German Patent Application no. 10 2016 109 709.8, International PCT Patent Application no. PCT\/EP2017\/062618). S.F. is an employee of F. Hoffmann-La Roche Ltd, Basel, Switzerland. B.D.H. is author of the University of California patents on sEH inhibitors licensed to EicOsis. None of the other authors has any disclosures to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}